Tag: Covishield

The State government of Odisha on Friday announced to introduce Covaxin for inoculation of people aged 18 years and above in the district of Ganjam. Manufactured by the Bharat Biotech will be soon rolled out for vaccinating people in Ganjam district including the Berhampur Municipal Corporation area from the month of July.

The Odisha government on Wednesday stopped the COVID-19 vaccination drive in 11 districts due to an "acute shortage" of Covishield doses

The State Health Department of Odisha has appealed to the people to take Covid-19 vaccine shot as early as possible and adhere to the appropriate Covid protocols ahead of a possible third wave of the pandemic that has already hit other countries.

As per experts, a vaccine will be considered a marathoner protector if it is able to produce good spike protein antibodies. A spike protein antibody test can confirm whether claims made by Covisheild and Covaxin are true

On the decision to increase the gap between two doses of Covishield from four-six weeks to 12-16 weeks, he said the move was based on scientific decision and there was no dissenting voice among the National Technical Advisory Group on Immunisation (NTAGI) members.

Noting that 60 per cent to 70 per cent of the children who got infected and got admitted in hospitals during the second wave in India, had either comorbidities or low immunity, the All India Institute of Medical Sciences (AIIMS) Director said that healthy children recovered with mild illness without need for hospitalisation.

The maximum price of Covishield for private COVID-19 Vaccination Centres (CVCs) has been fixed at Rs 780 per dose, while that of Covaxin is Rs 1,410 per dose and Sputnik V Rs 1,145 per dose, it said.

The series of lockdowns and shutdowns enforced by the State government of Odisha has really fructified results as anticipated, DMET CBK Mohanty said today.

A latest study has found that both vaccines, Covishield and Covaxin elicited a good immune response after two doses, although seropositivity rates and the median anti-spike antibody titre was significantly higher in Covishield as compared to Covaxin.

Vaccine manufacturer, Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking permission to manufacture Russian COVID vaccine Sputnik V in India. As per sources, the Pune-based vaccine maker has also sought permission for test analysis and examination.

The Odisha Health and Family Welfare Department on Wednesday issued advisory for the physicians and beneficiaries to report suspected Thrombosis after Covishield vaccine administration.

The Union government has reiterated to the states/UTs that online appointments booked for second dose of Covishield prior to this change of the interval between the two doses of Covishield, must be honoured.

Gap between two doses of Covishield vaccine increased. A day after the Union Health ministry increased the gap between 2 doses of Covishield, Odisha announced the changes. Union Health Ministry widened the gap between 2 doses of Covishield from 42 days (6 weeks) to 84 days

The Ministry of Health and Family Welfare (MoHFW) had on Thursday widened the gap between two doses of Serum Institute of India’s Covidshield vaccine from 42 days (6 weeks) to 84 days (12weeks).

The Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks.